Literature DB >> 11352799

Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in rats.

P Schemmer1, N Enomoto, B U Bradford, H Bunzendahl, J A Raleigh, J J Lemasters, R G Thurman.   

Abstract

Harvesting trauma to the graft dramatically decreases survival after liver transplantation. Since activated Kupffer cells play a role in primary nonfunction, the purpose of this study was to test the hypothesis that organ manipulation activates Kupffer cells. To mimic what occurs with donor hepatectomy, livers from Sprague-Dawley rats underwent dissection with or without gentle organ manipulation in a standardized manner in situ. Perfused livers exhibited normal values for O(2) uptake (105 +/- 5 micromol. g(-1). h(-1)) measured polarigraphically; however, 2 h after organ manipulation, values increased significantly to 160 +/- 8 micromol. g(-1). h(-1) and binding of pimonidazole, a hypoxia marker, increased about threefold (P < 0.05). Moreover, Kupffer cells from manipulated livers produced three- to fourfold more tumor necrosis factor-alpha and PGE(2), whereas intracellular calcium concentration increased twofold after lipopolysaccharide compared with unmanipulated controls (P < 0.05). Gadolinium chloride and glycine prevented both activation of Kupffer cells and effects of organ manipulation. Furthermore, indomethacin given 1 h before manipulation prevented the hypermetabolic state, hypoxia, depletion of glycogen, and release of PGE(2) from Kupffer cells. These data indicate that gentle organ manipulation during surgery activates Kupffer cells, leading to metabolic changes dependent on PGE(2) from Kupffer cells, which most likely impairs liver function. Thus modulation of Kupffer cell function before organ harvest could be beneficial in human liver transplantation and surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352799     DOI: 10.1152/ajpgi.2001.280.6.G1076

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  13 in total

1.  Can current technology be integrated to facilitate laparoscopic living donor hepatectomy?

Authors:  E Lin; R Gonzalez; K R Venkatesh; S G Mattar; S P Bowers; K M Fugate; T G Heffron; C D Smith
Journal:  Surg Endosc       Date:  2003-03-06       Impact factor: 4.584

Review 2.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice.

Authors:  Felix Heymann; Patricia M Niemietz; Julia Peusquens; Can Ergen; Marlene Kohlhepp; Jana C Mossanen; Carlo Schneider; Michael Vogt; Rene H Tolba; Christian Trautwein; Christian Martin; Frank Tacke
Journal:  J Vis Exp       Date:  2015-03-24       Impact factor: 1.355

4.  Anti-inflammatory role of glycine in reducing rodent postoperative inflammatory ileus.

Authors:  B Stoffels; A Türler; J Schmidt; A Nazir; T Tsukamoto; B A Moore; C Schnurr; J C Kalff; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-10-01       Impact factor: 3.598

5.  Signs of reperfusion injury following CO2 pneumoperitoneum: an in vivo microscopy study.

Authors:  Arash Nickkholgh; Miriam Barro-Bejarano; Rui Liang; Markus Zorn; Arianeb Mehrabi; Martha-Maria Gebhard; Markus W Büchler; Carsten N Gutt; Peter Schemmer
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

6.  HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation.

Authors:  Qinlong Liu; Helge Bruns; Daniel Schultze; Yi Xue; Markus Zorn; Christa Flechtenmacher; Beate K Straub; Ursula Rauen; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2012-11-01       Impact factor: 3.445

7.  Small-for-Size Liver Transplantation Increases Pulmonary Injury in Rats: Prevention by NIM811.

Authors:  Qinlong Liu; Hasibur Rehman; Russell A Harley; John J Lemasters; Zhi Zhong
Journal:  HPB Surg       Date:  2012-05-22

Review 8.  Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.

Authors:  Judith Kahn; Peter Schemmer
Journal:  Visc Med       Date:  2018-10-30

9.  Effects of a preconditioning oral nutritional supplement on pig livers after warm ischemia.

Authors:  Arash Nickkholgh; Zhanqing Li; Xue Yi; Elvira Mohr; Rui Liang; Saulius Mikalauskas; Marie-Luise Gross; Markus Zorn; Steffen Benzing; Heinz Schneider; Markus W Büchler; Peter Schemmer
Journal:  HPB Surg       Date:  2012-06-25

10.  HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

Authors:  Steffen P Luntz; Kristina Unnebrink; Monika Seibert-Grafe; Hartwig Bunzendahl; Thomas W Kraus; Markus W Büchler; Ernst Klar; Peter Schemmer
Journal:  BMC Surg       Date:  2005-08-17       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.